109 related articles for article (PubMed ID: 20956014)
21. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
Brodzki LM
Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
[No Abstract] [Full Text] [Related]
22. [Bone marrow necrosis in acute leukemias].
Schneider WA; Kurrle E; Heimpel H
Internist (Berl); 1988 Jan; 29(1):46-50. PubMed ID: 3280512
[No Abstract] [Full Text] [Related]
23. Theranostic drug test incorporating the bone-marrow microenvironment can predict the clinical response of acute myeloid leukaemia to chemotherapy.
Dhami SPS; Tirincsi A; Baev D; Krawczyk J; Quinn J; Cahill MR; Zeugolis D; Szegezdi E
Br J Haematol; 2020 Jun; 189(6):e254-e258. PubMed ID: 32342487
[No Abstract] [Full Text] [Related]
24. Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy.
Matsunaga T; Imataki O; Torii E; Kameda T; Shide K; Shimoda H; Kamiunten A; Sekine M; Taniguchi Y; Yamamoto S; Hidaka T; Katayose K; Kubuki Y; Dobashi H; Bandoh S; Ohnishi H; Fukai F; Shimoda K
Leuk Res; 2012 Jun; 36(6):e122-4. PubMed ID: 22444690
[No Abstract] [Full Text] [Related]
25. Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia.
Fiegl M; Spiekermann K
Leuk Res; 2011 May; 35(5):573-4. PubMed ID: 21163529
[No Abstract] [Full Text] [Related]
26. Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case report.
Christoulas D; Matsouka C; Chatzinikolaou I; Barmparoussi D; Dimopoulos MA; Papadimitriou CA
J Clin Oncol; 2011 Apr; 29(11):e295-6. PubMed ID: 21245430
[No Abstract] [Full Text] [Related]
27. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
Badar T; Shetty A; Bueso-Ramos C; Cortes J; Konopleva M; Borthakur G; Pierce S; Huang X; Chen HC; Kadia T; Daver N; Dinardo C; O'Brien S; Garcia-Manero G; Kantarjian H; Ravandi F
Am J Hematol; 2015 Sep; 90(9):769-73. PubMed ID: 26017166
[TBL] [Abstract][Full Text] [Related]
29. Distribution of the cytoskeletal protein, Nestin, in acute leukemia.
Du X; Yang XH; Wu YF; Liang J; Zhang J; Huang ZC; Zhu ZP; Lin W; Zou MX; Wen JY; Wu SJ; Guo R; Zhang XM; Lahn BT; He F; Xiang AP
Biotech Histochem; 2015 Jul; 90(5):384-94. PubMed ID: 25839093
[TBL] [Abstract][Full Text] [Related]
30. [A case of acute promyelocytic leukemia with remarkable elevation of serum LDH and multiple bone marrow necroses at autopsy (author's transl)].
Iwata J; Tanabe A; Miyake K; Kamakura M; Ohashi T; Oda T; Tange T; Oikawa T
Rinsho Ketsueki; 1980 Nov; 21(11):1802-7. PubMed ID: 6937698
[No Abstract] [Full Text] [Related]
31. Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
Mangaru Z; Shetty S; Visconte V; Liu HD; Rogers HJ
Am J Hematol; 2016 Jun; 91(4):E273-4. PubMed ID: 26719044
[No Abstract] [Full Text] [Related]
32. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
[No Abstract] [Full Text] [Related]
33. [Correlation between bone and marrow during treatment of acute granulocytic leukemia (author's transl)].
Okita H; Block M
Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):8-14. PubMed ID: 295564
[No Abstract] [Full Text] [Related]
34. Acute promyelocytic leukaemia--hypergranular and microgranular variants.
Nandakumar A; Bhargava MK; Lalitha N
Indian J Cancer; 1983; 20(4):185-90. PubMed ID: 6586687
[No Abstract] [Full Text] [Related]
35. Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients.
Mondet J; Laurin D; Lo Presti C; Jacob MC; Meunier M; Giraudon E; Lefebvre C; Berthier S; Leer AM; Park S; Mossuz P
Hematol Oncol; 2020 Feb; 38(1):114-118. PubMed ID: 31904882
[No Abstract] [Full Text] [Related]
36. [Bone marrow changes in acute non-lymphocytic leukemia patients treated with low-dose Ara-C--implications of therapeutic mechanism].
Lin SF; Liu HW; Chen JR; Chien CH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Sep; 3(9):612-7. PubMed ID: 3483023
[No Abstract] [Full Text] [Related]
37. Identification of Charcot-Leyden crystals by electron microscopy.
Carson HJ; Buschmann RJ; Weisz-Carrington P; Choi YS
Ultrastruct Pathol; 1992; 16(4):403-11. PubMed ID: 1502737
[TBL] [Abstract][Full Text] [Related]
38. Erythrophagocytosis of myeloblasts in acute myeloid leukaemia exhibiting chromosome 8p abnormality and extramedullary disease.
Yin T; Burthem J; McAlpine A; Telford N
Br J Haematol; 2015 Jul; 170(2):139. PubMed ID: 26032646
[No Abstract] [Full Text] [Related]
39. Charcot-Leyden crystals.
Grigoriadis G; Anderson MA; Whitehead S
Intern Med J; 2010 Nov; 40(11):792. PubMed ID: 21155159
[No Abstract] [Full Text] [Related]
40. Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.
Lyall H; O'Connor S; Clark D
Br J Haematol; 2007 Aug; 138(4):405. PubMed ID: 17593250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
